Compare IDYA & OLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | OLN |
|---|---|---|
| Founded | 2015 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.0B |
| IPO Year | 2019 | 1994 |
| Metric | IDYA | OLN |
|---|---|---|
| Price | $27.99 | $27.78 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 16 | 13 |
| Target Price | ★ $52.86 | $25.23 |
| AVG Volume (30 Days) | 1.4M | ★ 2.0M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.92% |
| EPS Growth | ★ 61.90 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $218,710,000.00 | ★ $6,780,800,000.00 |
| Revenue This Year | N/A | $2.57 |
| Revenue Next Year | $201.05 | $3.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3024.43 | 3.68 |
| 52 Week Low | $17.17 | $18.08 |
| 52 Week High | $39.28 | $30.46 |
| Indicator | IDYA | OLN |
|---|---|---|
| Relative Strength Index (RSI) | 36.30 | 50.85 |
| Support Level | $26.05 | $22.82 |
| Resistance Level | $28.05 | $29.86 |
| Average True Range (ATR) | 1.15 | 1.30 |
| MACD | -0.12 | -0.04 |
| Stochastic Oscillator | 7.68 | 56.70 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.